Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News
SYS-CON.TV
Cloud Expo & Virtualization 2009 East
PLATINUM SPONSORS:
IBM
Smarter Business Solutions Through Dynamic Infrastructure
IBM
Smarter Insights: How the CIO Becomes a Hero Again
Microsoft
Windows Azure
GOLD SPONSORS:
Appsense
Why VDI?
CA
Maximizing the Business Value of Virtualization in Enterprise and Cloud Computing Environments
ExactTarget
Messaging in the Cloud - Email, SMS and Voice
Freedom OSS
Stairway to the Cloud
Sun
Sun's Incubation Platform: Helping Startups Serve the Enterprise
POWER PANELS:
Cloud Computing & Enterprise IT: Cost & Operational Benefits
How and Why is a Flexible IT Infrastructure the Key To the Future?
Click For 2008 West
Event Webcasts
Discriminatory Vaccine Policy Based on Falsified Paper

WASHINGTON, Nov. 17, 2012 /PRNewswire/ -- CoMeD -- As the Inspector General for Health and Human Services names vaccine researcher Poul Thorsen as one of its "Most Wanted" fugitives, the defense of mercury as 'safe in vaccines' seems to be crumbling.

In 2010, the Coalition for Mercury-free Drugs (CoMeD, Inc.) submitted an allegation to the Inspector General, that studies showing mercury-containing vaccines to be safe, are fraudulent. Now, a new "wanted" posted featuring Danish vaccine researcher Poul Thorsen, issued by the Inspector General  (HHS-OIG), offers proof this allegation is credible.

It is estimated that Poul Thorsen embezzled at least one million dollars of grant money from the CDC, while he co-authored, "Thimerosal and the occurrence of autism …".  CDC documents, obtained through FOIA, also show that Thorsen and his co-authors concealed the fact that autism declined in Denmark after Thimerosal was removed from the Danish vaccine program. 

Today, the US Government and the World Health Organization defend the ongoing use of Thimerosal, the highly toxic mercury-based vaccine preservative, based on a handful of industry-sponsored statistical studies, including Thorsen's. The manufacturer's Material Safety Data Sheet for Thimerosal, however, lists mental retardation as a possible outcome from exposure in utero and in children.  

Based on Thorsen's public conclusion, Dr. Jose Cordero, former US Assistant Surgeon General, declared that "(Thorsen's) Danish study…provide(s) one strong piece of evidence that Thimerosal is not causally linked to autism." Disturbingly, this study also helped the Institute of Medicine reach its 2004 declaration that mercury in vaccines is unrelated to the autism epidemic.

Globally, the proponents for Thimerosal-preserved vaccines are using this questionable research to justify providing mercury-preserved vaccines to developing countries.  While children in developed, western, nations receive mercury-free vaccine formulations, children in developing countries receive many mercury-preserved ones.

At the fourth meeting of the United Nations Intergovernmental Negotiating Committee (INC4) to write a global treaty on mercury, Rev. Lisa K. Sykes, President of CoMeD, Inc., termed this double standard in vaccine safety a form of discrimination based on economics and nationality.  It now seems this discrimination is also based upon falsified data and criminal conduct.

Despite this, the US National Institutes of Health and Centers for Disease Control and Prevention continue to collaborate with Poul Thorsen, using federal funds.  Thorsen remains in Denmark, and no date for his extradition has been made public.

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Cloud Developer Stories
Mobile device usage has increased exponentially during the past several years, as consumers rely on handhelds for everything from news and weather to banking and purchases. What can we expect in the next few years? The way in which we interact with our devices will fundamentally ...
SYS-CON Events announced today that SourceForge has been named “Media Sponsor” of SYS-CON's 21st International Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. SourceForge is the largest, most trusted destination ...
SYS-CON Events announced today that DXWorldExpo has been named “Global Sponsor” of SYS-CON's 21st International Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Digital Transformation is the key issue driving the ...
One of the biggest challenges with adopting a DevOps mentality is: new applications are easily adapted to cloud-native, microservice-based, or containerized architectures - they can be built for them - but old applications need complex refactoring. On the other hand, these new te...
Cloud-based disaster recovery is critical to any production environment and is a high priority for many enterprise organizations today. Nearly 40% of organizations have had to execute their BCDR plan due to a service disruption in the past two years. Zerto on IBM Cloud offer VMwa...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021



SYS-CON Featured Whitepapers
ADS BY GOOGLE